
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Mucinous cystadenocarcinoma epidemiology and demographics
Introduction
For patient information, click here
Overview
Overview
Mucinous cystadenocarcinoma commonly affects individuals older than forty years of age. Females are more commonly affected with mucinous cystadenoma of pancreas than males.
Epidemiology and Demographics
Epidemiology and Demographics
Incidence
Mucinous cystadenoma of ovary
- 3 to 4 percent of primary ovarian cancers is mucinous cancers of the ovary.[1][2][3]
- With predominance in perimenopausal women late 40s to early 50s.
- Account for 10 to 15% of all ovarian tumors.[1][4][5][6]
- Benign mucinous cystadenomas make 80 percent of these.
Mucinous cystadenoma of pancreas
- Mostly in perimenopausal women in late 40s to early 50s.[7]
- More common in females than males.
Mucinous cystadenoma of appendix
- Appendiceal mucinous neoplasms are rare.
- 1000 to 2000 cases are diagnosed annually in the United States.[8]
- More common in females.[9]
- Age of diagnosis 50s and 60s.[10]
References
References
- β 1.0 1.1 Hart WR, Norris HJ (May 1973). “Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior”. Cancer. 31 (5): 1031β45. PMIDΒ 4735836.
- β Riopel MA, Ronnett BM, Kurman RJ (June 1999). “Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas”. Am. J. Surg. Pathol. 23 (6): 617β35. PMIDΒ 10366144.
- β Hoerl HD, Hart WR (December 1998). “Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up”. Am. J. Surg. Pathol. 22 (12): 1449β62. PMIDΒ 9850171.
- β Bladt O, De Man R, Aerts R (2004). “Mucinous cystadenoma of the ovary”. JBR-BTR. 87 (3): 118β9. PMIDΒ 15293671.
- β de Nictolis M, Montironi R, Tommasoni S, Valli M, Pisani E, Fabris G, Prat J (January 1994). “Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases”. Int. J. Gynecol. Pathol. 13 (1): 10β21. PMIDΒ 8112952.
- β Hart WR (January 2005). “Mucinous tumors of the ovary: a review”. Int. J. Gynecol. Pathol. 24 (1): 4β25. PMIDΒ 15626914.
- β Lee KR, Scully RE (November 2000). “Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with ‘pseudomyxoma peritonei‘“. Am. J. Surg. Pathol. 24 (11): 1447β64. PMIDΒ 11075847.
- β Choudry HA, Pai RK (August 2018). “Management of Mucinous Appendiceal Tumors”. Ann. Surg. Oncol. 25 (8): 2135β2144. doi:10.1245/s10434-018-6488-4. PMIDΒ 29717422.
- β Aho AJ, Heinonen R, LaurΓ©n P (1973). “Benign and malignant mucocele of the appendix. Histological types and prognosis”. Acta Chir Scand. 139 (4): 392β400. PMIDΒ 4718184.
- β Landen S, Bertrand C, Maddern GJ, Herman D, Pourbaix A, de Neve A, Schmitz A (November 1992). “Appendiceal mucoceles and pseudomyxoma peritonei”. Surg Gynecol Obstet. 175 (5): 401β4. PMIDΒ 1440166.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Ammu Susheela, M.D. [3]
